Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients With Hyperkalemia

PharmacoEconomics - United Kingdom
doi 10.1007/s40273-018-0709-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Puk17 - A Cost-Effectiveness Analysis of Raasi – Enabling Patiromer for the Treatment of Hyperkalemia in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Supervised Exercise Therapy in Heart Failure Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Psy115 - A Cost-Effectiveness Analysis of Raasi – Enabling Patiromer for the Treatment of Hyperkalemia in Austria

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Cost-Effectiveness of Eplerenone in NYHA Class II Chronic Heart Failure Patients With Reduced LVEF: An Analysis for Greece

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2016English

Effects of Mineralocorticoid Receptor Antagonist Spironolactone on Atrial Conduction and Remodeling in Patients With Heart Failure

Journal of Cardiology
Cardiovascular MedicineCardiology
2011English

Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial FibrillationCLINICAL PERSPECTIVE

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2016English

Pharmacoeconomic Analysis of Chronic Heart Failure Drug Therapy in Patients With Comorbid Conditions

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2018English

Cost-Effectiveness Analysis of Standard Therapy With Phosphocreatine VS Standard Therapy in Perioperative Management of Cardiac Surgery Patients With Extracorporeal Circulation, With Ischemic Heart Disease or With Chronic Heart Insufficiency

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy